파클리탁셀 약물 시장 조사 – 규모, 점유율, 개발 및 미래 범위 2031

  • Report Code : TIPRE00022333
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

시장 소개

파클리탁스는 항암제 계열의 항암제에 속합니다. 항산화제는 암세포의 발달을 돕는 영양소를 제거함으로써 작용하며 비소세포폐암, 유방암 등과 같은 질환의 치료에 널리 사용됩니다. 파클리탁스는 항종양제 계열에 속합니다. 레스베라트롤은 여러 유형의 암, 특히 유방암, 난소암, 소세포폐암 및 비소세포폐암종과 같은 비소세포폐암의 치료에서 합성되므로 이러한 질병에 대한 화학요법제 역할을 합니다.

시장 범위

"2031년까지의 글로벌 파클리탁셀 약물 시장 분석"은 식품 및 음료 산업에 대한 전문적이고 심층적인 연구입니다. 특히 글로벌 시장 동향 분석에 중점을 두고 있습니다. 이 보고서는 유형, 최종 용도 및 지역별로 상세한 시장 세분화를 통해 파클리탁셀 약물 시장에 대한 개요를 제공하는 것을 목표로 합니다. 이 보고서는 주요 파클리탁셀 약물 시장 플레이어의 시장 상태에 대한 주요 통계를 제공하고 시장의 주요 추세와 기회를 제공합니다.

시장 세분화
    •  유형에 따라 전 세계 파클리탁셀 약물 시장은 전립선암, 유방암, 비소세포폐암, AIDS 관련 카포시 육종, 난소암, 위암, 자궁경부암, 식도암, 고환암, 폐암, 췌장암으로 분류됩니다. , 기타.•  최종 용도를 기준으로 시장은 암 연구 센터, 병원, 기타로 분류됩니다.
시장 역학

동인-
    •  이러한 수요의 주요 동인은 파클리탁셀 효능의 발전입니다.•  널리 받아들여지는 암치료
억제-
    •  둘째, 약물이상반응, 개인별 필요에 맞춘 치료법, 새로운 항암치료법 개발 등이 등장하고 있다.


보고서는 다음과 같은 내용을 제공한다. 질적, 양적 정보를 모두 포함하는 업계에 대한 자세한 개요. 다양한 부문을 기반으로 글로벌 시장에 대한 개요 및 예측을 제공합니다. 또한 5개 주요 지역에 대해 2021년부터 2031년까지 시장 규모와 예측 추정치를 제공합니다. 북미, 유럽, 아시아 태평양(APAC), 중동 및 아프리카(MEA) 및 남미. 각 지역별 파클리탁셀 약물 시장은 나중에 각 국가 및 부문별로 세분화됩니다. 이 보고서는 전 세계 18개국에 대한 분석 및 예측과 함께 이 지역에 만연한 현재 추세 및 기회를 다루고 있습니다.

이 보고서는 수요와 공급 측면 모두에서 시장에 영향을 미치는 요인을 분석하고 추가로 영향을 미치는 시장 역학을 평가합니다. 예측 기간 동안의 시장, 즉 동인, 제약, 기회 및 미래 추세. 이 보고서는 또한 5개 지역 모두에 대한 철저한 PEST 분석을 제공합니다. 북미, 유럽, APAC, MEA 및 남미 지역의 파클리탁셀 약물 시장에 영향을 미치는 정치적, 경제적, 사회적 및 기술적 요인을 평가한 후.

파클리탁셀 약물에 대한 코로나19의 영향 시장

유방암 환자는 일반 인구에 비해 코로나바이러스에 감염될 가능성이 더 높습니다. 이것을 보려면 면역체계를 살펴보기만 하면 됩니다. 결과적으로 제조업체는 의료 산업의 공급망 중단에 앞서기 위해 주사 성형 역량을 강화하고 있습니다. 치료를 받지 않는 환자도 치료가 장기적인 결과를 가져오기 때문에 CO19 전염에 취약합니다. 결과적으로 경쟁이 치열한 파클리탁스 주사 시장에서 활동하는 기업들은 경제를 유지하기 위해 특정한 노력을 기울이고 있습니다.

시장 참가자

이 보고서는 유기 및 무기 성장 전략으로서 파클리탁셀 약물 시장의 주요 발전을 다루고 있습니다. 다양한 기업들이 제품 출시, 제품 승인, 특허, 이벤트 등 유기적인 성장 전략에 주력하고 있습니다. 시장에서 목격되는 무기 성장 전략 활동은 인수, 파트너십 & 협력. 이러한 활동은 시장 참가자의 비즈니스 및 고객 기반 확장을 위한 기반을 마련했습니다. 파클리탁셀 약물 시장의 시장 지불자는 글로벌 시장에서 파클리탁셀 약물에 대한 수요가 증가함에 따라 향후 수익성 있는 성장 기회가 있을 것으로 예상됩니다.

이 보고서에는 파클리탁셀 약물 시장의 SWOT 분석 및 시장 전략과 함께 주요 회사의 프로필도 포함되어 있습니다. 또한 이 보고서는 회사 프로필, 구성 요소, 제공된 서비스, 지난 3년간의 재무 정보, 지난 5년간의 주요 발전 등의 정보를 제공하는 업계 선두 기업에 초점을 맞췄습니다.
    •  Abraxis Bio Science Inc.•  세엘진•  애보트 연구소•  Fresenius Kabi 종양학 Ltd•  Oncotherapy Ltd•  Novasep•  Sagent Pharmaceuticals•  루예 제약 그룹•  Youcare Pharmaceutical Group Co., Ltd.•  BEIJING Union Pharmaceutical Factory
Insight Partner의 전담 연구 및 분석 팀은 고급 통계 전문 지식을 갖춘 숙련된 전문가로 구성되어 있으며 기존 연구에서 다양한 사용자 정의 옵션을 제공합니다.
  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Global, Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


At what CAGR the paclitaxel drug market is projected to grow?

The market is expected to grow at a CAGR of 6.3%

Major driver boosting the paclitaxel drug market growth?

Rising Cancer Incidences and Novel Formulation Developments is the major factors boosting the paclitaxel drug market growth

Which region accounts for highest revenue share paclitaxel drug market?

The North America region accounts for highest revenue share paclitaxel drug market

What years does this paclitaxel drug market cover?

The final report will duly include market size and projection estimates for all the segments from 2021 to 2031, along with a revenue share and compound annual growth rate (%) for the regional
/
country-wise market wherein 2021-2022 are the historic years, 2023 is considered to be the base year, and the forecast will be provided till 2031, along with CAGR (%)

Which is the fastest growing region in paclitaxel drug market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast year (2023 - 2031)

Who are the prominent players in paclitaxel drug market?

Abraxis Bio Science Inc., Celgene, Abbott Laboratories, Fresenius Kabi, Onco therapies Ltd are the major companies operating in the paclitaxel drug market

Trends and growth analysis reports related to Life Sciences : READ MORE..   
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

The List of Companies

1. Abraxis Bio Science Inc.
2. Celgene
3. Abbott Laboratories
4. Fresenius Kabi Oncology Ltd
5. Onco therapies Ltd
6. Novasep
7. Sagent Pharmaceuticals
8. Luye Pharma Group
9. Youcare Pharmaceutical Group Co., Ltd.
10. BEIJING Union Pharmaceutical Factory

Buy Now  

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.